BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 19505813)

  • 1. Tuberculosis vaccine research: the impact of immunology.
    Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of vaccine research and development: tuberculosis.
    Girard MP; Fruth U; Kieny MP
    Vaccine; 2005 Dec; 23(50):5725-31. PubMed ID: 16153751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of vaccines against tuberculosis directed by basic immunology.
    Reece ST; Kaufmann SH
    Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M; Kita Y
    Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent findings in immunology give tuberculosis vaccines a new boost.
    Kaufmann SH
    Trends Immunol; 2005 Dec; 26(12):660-7. PubMed ID: 16246622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
    Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
    Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in tuberculosis vaccine development.
    Baumann S; Nasser Eddine A; Kaufmann SH
    Curr Opin Immunol; 2006 Aug; 18(4):438-48. PubMed ID: 16777396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis due to high-dose challenge in partially immune individuals: a problem for vaccination?
    Rook GA; Hernández-Pando R; Zumla A
    J Infect Dis; 2009 Mar; 199(5):613-8. PubMed ID: 19199549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
    Dietrich J; Doherty TM
    APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future vaccination strategies against tuberculosis: thinking outside the box.
    Kaufmann SH
    Immunity; 2010 Oct; 33(4):567-77. PubMed ID: 21029966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in tuberculosis vaccine strategies.
    Skeiky YA; Sadoff JC
    Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvants in tuberculosis vaccine development.
    Moreno-Mendieta SA; Rocha-Zavaleta L; Rodriguez-Sanoja R
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):75-84. PubMed ID: 20002177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity.
    Sable SB; Kalra M; Verma I; Khuller GK
    Clin Immunol; 2007 Mar; 122(3):239-51. PubMed ID: 17208519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fact and fiction in tuberculosis vaccine research: 10 years later.
    Kaufmann SH
    Lancet Infect Dis; 2011 Aug; 11(8):633-40. PubMed ID: 21798463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mutant mycobacteria as new vaccines to prevent tuberculosis.
    Hernàndez Pando R; Aguilar LD; Infante E; Cataldi A; Bigi F; Martin C; Gicquel B
    Tuberculosis (Edinb); 2006; 86(3-4):203-10. PubMed ID: 16542875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of vaccines against tuberculosis.
    Tyagi AK; Nangpal P; Satchidanandam V
    Tuberculosis (Edinb); 2011 Sep; 91(5):469-78. PubMed ID: 21334259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy.
    Glatman-Freedman A
    Tuberculosis (Edinb); 2006; 86(3-4):191-7. PubMed ID: 16584923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.